Linagliptin
Faahfaahinta Alaabta
Tags Product
| Cabbirka Xidhmada | Helitaanka | Qiimaha (USD) |
Magaca Kiimikada:
8-[(3R) -3-aminopperidin-1-yl]-7-(laakin-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3 ,7-dihydro-1H-purine-2,6-dione
Koodhka dhoola cadeynta:
O=C(N1CC2=NC(C)=C3C=CC=CC3=N2)N(C)C4=C(N(CC#CC)C(N5C[C@H](N)CCC5=N4)C1 =O
Koodhka InChi:
InChi=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35) 33 (23 (21 )34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2 ,1-3H3/t17-/m1/s1
Furaha InChi:
LTXREWYXXSTFRX-QGZVFWFLSA-N
Ereyga muhiimka ah:
Linagliptin, BI-1356, BI 1356, BI1356, 668270-12-0
Xalka:Ku milmay DMSO
Kaydinta:0 - 4°C muddo gaaban (maalmo ilaa toddobaadyo), ama -20°C muddo dheer (bilo).
Sharaxaad:
Linagliptin, oo sidoo kale loo yaqaan BI-1356, waa DPP-4 inhibitor oo ay samaysay Boehringer Ingelheim si loogu daweeyo nooca II ee sonkorowga. Linagliptin (maalintii hal mar) waxaa ansixiyay FDA US 2dii Maajo 2011 daawaynta nooca II ee sonkorowga. Waxaa suuq geynaya Boehringer Ingelheim iyo Lilly.
Ujeedka: DPP-4
